The accurate delivery of stereotactic body radiotherapy (SBRT) for definitive prostate cancer treatment is aided by intrafraction image guidance. The common methods for intrafraction imaging require the invasive placement of fiducial markers or electromagnetic transponders. Recently, a magnetic resonance imaging (MRI)-guided tri-cobalt-60 head radiotherapy system has become available for treatment, which can utilize real-time cine MRI to non-invasively track prostate motion. We report on a clinical vignette using this technique to deliver SBRT for the definitive treatment of intermediate-risk prostate cancer. The incorporation of an MRI-guided radiotherapy system and the implementation of real-time adaptive dose delivery accounting for intrafraction anatomic motion may improve outcomes using this technique.
Hegde, J. V., Cao, M., Yu, V. Y., Kishan, A. U., Shaverdian, N., Lamb, J., & Steinberg, M. L. (2018). Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer. Cureus. https://doi.org/10.7759/cureus.2442